etiological diagnosis and pharmacotherapeutic management of ...
Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant...
-
Upload
elvin-hampshire -
Category
Documents
-
view
215 -
download
0
Transcript of Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant...
![Page 1: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/1.jpg)
Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders
Anantha Harijith, MDAssistant Professor of Pediatrics
University of Illinois, Chicago
![Page 2: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/2.jpg)
Case report Two month old male infant -
recently migrated from Kabul. Parents worked as interpreters in the US embassy.
Birth weight 3.1kg, Current weight 5.1kg-growing well
Parents –happy, only complaint-baby passing stools once in 5-7days
no newborn screen report
![Page 3: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/3.jpg)
Case report
Persistent jaundice, puffy coarse facies, large tongue, large anterior and posterior fontanelle, floppy, umbilical hernia, short arms, large pudgy hands
Parents are extremely happy with the baby and want you to prescribe prune juice for constipation. They are confident that investigations are unnecessary. What will you do?
Will you -Reassure the parents and see the patient again in two months OR will you investigate?
![Page 4: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/4.jpg)
Knee & Skull XR-
Our patient
They agree for X rays but no blood tests
What will you tell them? 1. X rays are normal and no further investigation needed now2. Immediate blood tests are needed
Another 2 month old healthy infant
![Page 5: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/5.jpg)
Blood tests done!
CBC Hematocrit 40%, WBC 9.8k, Platelet 202k
Serum Na141, K 4.6, Cl 105, HCO3- 25, Ca 9.8mg/dl
TSH-76 µIU/mL(Normal0.5 - 4.70 µIU/mL)
T4 and T3 – not detected What is the diagnosis?
![Page 6: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/6.jpg)
Parathyroid glands
![Page 7: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/7.jpg)
![Page 8: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/8.jpg)
• Thyroxine (T4, tetraiodothyronine)• Liothyronine (T3, triiodothyronine)
• Iodinated diphenyl ether structure• Built and stored on thyroglobulin• >99% protein bound in plasma• Only free form has physiologic effects
• T3 more potent; T4 longer lasting– Peripheral deiodination
![Page 9: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/9.jpg)
![Page 10: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/10.jpg)
![Page 11: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/11.jpg)
![Page 12: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/12.jpg)
![Page 13: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/13.jpg)
Hypothyroid Euthyroid Hyperthyroid
![Page 14: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/14.jpg)
• Increases transcription (nuclear)• Increases mitochondrial metabolism• Net effects are target dependent
– Oxygen consumption– Heat production– Metabolism, growth, differentiation– Promotes effects of hormones
• Steroids, catecholamines
Physiological Effects
![Page 15: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/15.jpg)
Congenital Hypothyroidism
1 in 4000 newborns 90% Thyroid agenesis maternal T4 crosses the placenta, entering
fetal blood well before the fetal thyroid is secreting its own T4
So early protection but in second trimester high demand for T4 not met by transfer- so signs of hypothyroidism sets in
Treatment- T4 ie Thyroxine supplementation
![Page 16: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/16.jpg)
Other causes
-Primary Idiopathic Autoimmune Traumatic Iatrogenic
-Secondary Pituitary dysfunction Increased protein binding
• estrogen; HIV; liver dysfunction; heroin
![Page 17: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/17.jpg)
Case Report38 y/o computer professional lady reports
over phone seeking an immediate appointment
palpitations, tremulousness for 6 months weight loss, heat intolerance of 12 weeks
duration Menstrual periods have been scanty for
6months She used to be a regular in Chicago
marathon until last year and wants to be tested for uterine problems because of lack of periods
She is now walking into your office
![Page 18: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/18.jpg)
PE reveals HR = 120 bpm BP = 170/90 fine tremor of
outstretched hands and
... …..
![Page 19: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/19.jpg)
Lab reports free T4 = 40 pmol/L, free T3 = 10.6 pmol/L
TSH – undetectable elevated thyroid-stimulating
globulins confirming a Dx of ?
![Page 20: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/20.jpg)
Hyperthyroidism
• Causes– Grave’s disease (TSHR autoantibodies)
• 0.1% to 1% prevalence, higher in women
– Thyroiditis– Toxic adenoma
• Non-pharmacologic treatments– Subtotal thyroidectomy– Radioiodine– Arterial embolization (2005)
![Page 21: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/21.jpg)
Grave’s Disease
![Page 22: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/22.jpg)
Pharmacologic Treatments• Thionamides (thiourelynes)
Hyperthyroidism
• Methimazole (Tapazole)– Typical dose 15 – 30 mg QD– Rapidly absorbed (Cmax < 2 hours)– Half-life 13 – 18 hours
• Propylthiouracil (PTU)– Typical dose 50– 600 mg BID– Good bioavailability– Half-life 2 – 4 hours– Blocks peripheral T4 -> T3 conversion
![Page 23: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/23.jpg)
Thionamide MOA
Coupling is also highly sensitive to drug
![Page 24: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/24.jpg)
![Page 25: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/25.jpg)
• Rash/itch• Fever• Rarely:
– Liver dysfunction– Leucocytopenia
Thionamide Side Effects
![Page 26: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/26.jpg)
Cooper DS. N Engl J Med 005;352:905-917.
![Page 27: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/27.jpg)
Other Antithyroid Options
Iodide loading• High doses can inhibit iodide formation• Effect transient• May be useful prior to RAI or surgery
Debulk and devascularize gland• Side effects
Rash, hypersalivation, oral ulcers CI in pregnancy (may cause fetal goiter)
![Page 28: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/28.jpg)
Other Antithyroid Options
Beta Blockers• Adjunctive treatment• May reduce T4 -> T3 conversion• Control HR and palpitations, sweats• Rapid action
Corticosteriods• Reduce T4 -> T3 conversion• May reduce TSHR antibody effect in Grave’s
![Page 29: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/29.jpg)
![Page 30: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/30.jpg)
Algorithm for the Use of Antithyroid Drugs among Patients with Graves' Disease.
![Page 31: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/31.jpg)
Thyroid Storm
Potentially life threatening Combined treatment strategy
• High dose PTU Give 1st; iodide will reduce drug uptake in gland
• Iodide loading (IV Lugol’s solution)• Beta blockers• Corticosteriods
![Page 32: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/32.jpg)
Chief cells-Small dark numerous -produce Parathyroid hormone (PTH)
Oxyphil cells -No known physiological function-May produce PTH related protein
Parathyroid Basics
![Page 33: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/33.jpg)
Parathyroid Basics
Parathyroid Hormone• Small molecule (34 amino acids)• Activity based on amino terminal• No disulfide linkages• Encoded on chromosome 11• Half-life only 2 – 4 minutes• Secreted by chief cells
![Page 34: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/34.jpg)
Case reportA 17 year old male was admitted with history of generalized seizures for 8 years
& involuntary movements for 2 months short statured (138 cm),had hypoplastic
dentition, thick dystrophic nails. The patient demonstrated tetany, a
positive Chvostek's sign and generalized hyper-reflexia. Systemic examination was normal.
![Page 35: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/35.jpg)
Labs: hypocalcaemia, hyperphosphataemiaEyes- Posterior subcapsular cataract CT Brain- basal ganglial calcification
Dx: ?
![Page 36: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/36.jpg)
Hypoparathyroidism
Causes• Surgical (most common)• Idiopathic
Genetic familial forms Circulating receptor antibodies
• Functional Due to hypomagnesemia
• Mg2+ necessary for PTH release
![Page 37: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/37.jpg)
Hypoparathyroidism Decreased bone resorption & osteocytic activity Hypocalcemia
• Increased neuromuscular excitability• Tetanic muscle contractions/spasms• Seizure• Prolonged QT interval• Cataract• Trousseau Sign• Chvostek Sign
Low or absent iPTH
![Page 38: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/38.jpg)
Psuedohypoparathyroidism
Target organs resistant to PTH• Congential defect of PTHR1
Plasma Ca2+ low Plasma phosphate high Renal phosphatase activity high
![Page 39: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/39.jpg)
Hypoparathyroidism
Maintenance Treatment• Combined oral calcium + Vitamin D• Phosphate restriction may be used
Acute Treatment• Tetany or Hungry Bone Syndrome
Parenteral calcium followed by vitamin D supp + oral calcium
![Page 40: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/40.jpg)
Hyperparathyroidism Primary
•Excess PTH high calcium, low phosphate Tumor, adenoma, hyperplasia
•More common in women•Marrow fibrosis•Osteitis fibrosa cystica•Metabolic acidosis•Increased Alk Phos •Kidney stones
![Page 41: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/41.jpg)
Hyperparathyroidism
Primary – Diagnosis• Multiple elevated Ca2+ serum tests• Elevated iPTH• Alk Phos typically low• Corticosteroid suppression test
Prednisolone reduces serum Ca2+• Indicates non-parathyroid origin
Sarcoid, vitamin D intoxication, etc.
![Page 42: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/42.jpg)
Hyperparathyroidism
Treatment• Acute Severe forms
Adequate hydration, forced diuresis• Other Agents
Corticosteroids – Blood malignancies Mythramycin
• Toxic antibiotic used to inhibit bone resorption – hematologic and solid neoplasms
![Page 43: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/43.jpg)
Hyperparathyroidism
Treatment• Other Agents
Calcitonin• Inhibits osteoclast activity and bone resorption
Biphosphonates• Given IV or orally to reduce bone resorption
Estrogen• Can be given to postmenopausal women with 1°
hyperparathyroidism as medical therapy
![Page 44: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/44.jpg)
Hyperparathyroidism
Treatment• Surgery
Definitive treatment
![Page 45: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/45.jpg)
2° Hyperparathyroidism
Adaptive & unrelated to intrinsic disease of glands
Due to chronic stimulation of glands by low serum Ca2+ levels
![Page 46: Pharmacotherapeutic approach to Thyroid and Parathyroid Disorders Anantha Harijith, MD Assistant Professor of Pediatrics University of Illinois, Chicago.](https://reader036.fdocuments.in/reader036/viewer/2022062515/56649c775503460f9492c308/html5/thumbnails/46.jpg)
2° Hyperparathyroidism
Causes• Dietary deficiency of vitamin D or Ca2+• Decreased intestinal absorption of vitamin D
or Ca2+• Drugs such as phenytoin, phenobarbital• Renal Failure
Decreased activation of vitamin D3• Hypomagnesemia